ASCEMBL phase 3 health-related quality of life (HRQL) comparison of asciminib and bosutinib for patients with chronic myelogenous leukemia in chronic phase (CML-CP), previously treated with 2 or more tyrosine kinase inhibitors (TKI) Meeting Abstract
| Authors: | Mauro, M. J.; Boquimpani, C.; Rea, D.; Hochhaus, A.; Maheshwari, V. K.; Allepuz, A.; Patwardhan, P.; Wu, Y.; DeRosa, M.; Minami, Y. |
| Abstract Title: | ASCEMBL phase 3 health-related quality of life (HRQL) comparison of asciminib and bosutinib for patients with chronic myelogenous leukemia in chronic phase (CML-CP), previously treated with 2 or more tyrosine kinase inhibitors (TKI) |
| Meeting Title: | 9th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | cml; chronic myeloid leukemia; health-related quality of life; asciminib |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 21 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Sep 8-11 |
| Meeting Location: | Virtual event |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-09-01 |
| Start Page: | S336 |
| Language: | English |
| ACCESSION: | WOS:000691910500223 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(21)01785-7 |
| Notes: | Meeting Abstract: CML-417 -- Source: Wos |
